Here you can find the company’s latest financial figures, contact information, and source version of the press release to stay ahead of the market for value generation.

The forward-looking statements contained in this communication are based on the current expectations of Tevogen Bio, Semper Paratus and their respective management and are subject to risks and ...

29, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq ... These statements are based on the current beliefs and expectations of the Company’s management and are subject ...

New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today ...

New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation ... sustainability and commercial success in the current era of healthcare rely on ensuring patient ...

Immunotherapy developer Tevogen (TVGN) plans to go public through a merger with SPAC Semper Paratus Acquisition Corp. (NASDAQ:LGST), with the deal estimating the enterprise value of the combined ...

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that reflect Tevogen Bio’s and Semper ...

nasdaq 100 euro stoxx 50 ftse-100 ...